C84.49
Peripheral T-cell lymphoma, not elsewhere classified, extranodal and solid organ sites
Clinical Classification Guidelines
Medical Intelligence & Overview
Peripheral T-cell lymphoma not elsewhere classified (C84.49) is a rare type of non-Hodgkin lymphoma that originates from mature T-cells, a type of white blood cell involved in the immune response. This lymphoma typically affects lymph nodes but can also occur outside of lymphatic tissue, in solid organs and other extranodal sites. Due to its varied presentation and aggressive nature, understanding this condition is essential, even as treatments evolve to offer hope for affected individuals.
Causes & Symptoms
Clinical Causes: Genetic mutations affecting T-cell function and growth Chronic immune suppression or immunodeficiency conditions Exposure to certain chemicals or environmental toxins Previous autoimmune disorders Infections that influence immune cell behavior, such as certain viral infections
Key Symptoms: Swollen lymph nodes, especially in the neck, armpits, or groin Unexplained weight loss Persistent fever not caused by infection Night sweats Fatigue and weakness Abdominal pain or swelling if the spleen or liver is affected Skin patches, nodules, or ulcers in cases involving skin or other extranodal sites Shortness of breath or cough if the lungs are involved
Diagnostic & Treatment
Diagnosis Path: Physical examination focusing on lymph node enlargement and other signs Imaging tests such as CT scans or PET scans to locate and assess the extent of the disease Lymph node biopsy, often with histopathological and immunophenotypic analysis to identify T-cell origin Bone marrow biopsy to determine if the marrow is involved Blood tests to evaluate overall health and organ function Molecular and genetic studies to identify specific mutations or markers
Treatment Protocols: Chemotherapy regimens such as CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone) Targeted therapy aimed at specific tumor markers Immunotherapy to boost the body’s immune response Radiation therapy for localized or residual disease Stem cell transplant in eligible patients to improve long-term outcomes Supportive care to manage symptoms and improve quality of life
Clinical Advice & FAQs
Billing Guidance
Is C84.49 a billable ICD-10 code?
Yes, C84.49 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C84.49?
Clinical documentation must specify the nature of Peripheral T-cell lymphoma, not elsewhere classified, extranodal and solid organ sites and any associated comorbidities for accurate reporting.
Cite this Clinical Reference